p53: guardian of the genome and policeman of the oncogenes.

scientific article published on 28 May 2007

p53: guardian of the genome and policeman of the oncogenes. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.4161/CC.6.9.4211
P698PubMed publication ID17457049
P5875ResearchGate publication ID6372275

P50authorManuel SerranoQ42491729
Alejo EfeyanQ74118088
P2093author name stringManuel Serrano
Alejo Efeyan
P433issue9
P1104number of pages5
P304page(s)1006-1010
P577publication date2007-05-28
P1433published inCell CycleQ1254166
P1476titlep53: guardian of the genome and policeman of the oncogenes
P478volume6

Reverse relations

cites work (P2860)
Q35925499A DNA repair pathway-focused score for prediction of outcomes in ovarian cancer treated with platinum-based chemotherapy
Q28534098A Novel Anticancer Agent, 8-Methoxypyrimido[4',5':4,5]thieno(2,3-b) Quinoline-4(3H)-One Induces Neuro 2a Neuroblastoma Cell Death through p53-Dependent, Caspase-Dependent and -Independent Apoptotic Pathways
Q35002385A minimally invasive assay for individual assessment of the ATM/CHEK2/p53 pathway activity
Q28385864A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors
Q36016499A p53 axis regulates B cell receptor-triggered, innate immune system-driven B cell clonal expansion
Q33561621A planarian p53 homolog regulates proliferation and self-renewal in adult stem cell lineages
Q35890126ALDH3A1 Plays a Functional Role in Maintenance of Corneal Epithelial Homeostasis
Q39545413AP-2β enhances p53-mediated transcription of the αB-crystallin gene through stabilizing p53.
Q48015034Acetyl-11-keto-beta-boswellic acid (AKBA) prevents human colonic adenocarcinoma growth through modulation of multiple signaling pathways
Q27303150Acetylation of lysine 382 and phosphorylation of serine 392 in p53 modulate the interaction between p53 and MDC1 in vitro
Q39530180Acquisition of p53 mutations in response to the non-genotoxic p53 activator Nutlin-3.
Q37071040Alteration of WWOX in human cancer: a clinical view.
Q43053396Alterations in the p53 pathway and p16INK4a expression predict overall survival in metastatic melanoma patients treated with dacarbazine
Q33716323Alterations of tumor-related genes do not exactly match the histopathological grade in gastric adenocarcinomas
Q27014019An updated overview of HPV-associated head and neck carcinomas
Q42803501Analysis of cellular response to isocyanate using N-succinimidyl N-methylcarbamate exposure in cultured mammalian cells.
Q37139109Angiogenesis-related pathways in the pathogenesis of ovarian cancer
Q43543435Apoptosis induced by NS1 gene of Canine Parvovirus-2 is caspase dependent and p53 independent
Q37132824Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage-response thresholds
Q37703533Artemisinin derivative artesunate induces radiosensitivity in cervical cancer cells in vitro and in vivo
Q34176403Association of Mycoplasma hominis infection with prostate cancer
Q38994129Benzo(a)pyrene-7,8-diol-9,10-epoxide induced p53-independent necrosis via the mitochondria-associated pathway involving Bax and Bak activation
Q100295956Brca2 deficiency drives gastrointestinal tumor formation and is selectively inhibited by mitomycin C
Q37103465CCT241533 is a potent and selective inhibitor of CHK2 that potentiates the cytotoxicity of PARP inhibitors
Q37435152CHFR negatively regulates SIRT1 activity upon oxidative stress
Q64080731CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression
Q30496149Cancer biomarker discovery: the entropic hallmark
Q38910879Carbon ion beam triggers both caspase-dependent and caspase-independent pathway of apoptosis in HeLa and status of PARP-1 controls intensity of apoptosis
Q37511752Cause and consequences of genetic and epigenetic alterations in human cancer.
Q34089685Cellular Responses to Cisplatin‐Induced DNA Damage
Q34041305Cellular senescence: from physiology to pathology
Q38698137Characterization of the new human pleomorphic undifferentiated sarcoma TP53-null cell line mfh-val2.
Q33370291Characterization of the p53 response to oncogene-induced senescence
Q30992438Classifying the Progression of Ductal Carcinoma from Single-Cell Sampled Data via Integer Linear Programming: A Case Study
Q37835219Collateral damage: insights into bacterial mechanisms that predispose host cells to cancer
Q36959022Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers
Q91649552Comparison of responsiveness to cancer development and anti-cancer drug in three different C57BL/6N stocks
Q34162527Constant p53 pathway inactivation in a large series of soft tissue sarcomas with complex genetics
Q28910446Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway
Q37176269Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation
Q39515817DNA damage and DNA damage response in human bronchial epithelial BEAS-2B cells following exposure to 2-nitrobenzanthrone and 3-nitrobenzanthrone: role in apoptosis.
Q33988971DNA damage and DNA damage responses in THP-1 monocytes after exposure to spores of either Stachybotrys chartarum or Aspergillus versicolor or to T-2 toxin
Q39850003DNA damage regulates alternative splicing through inhibition of RNA polymerase II elongation.
Q34720959DNA replication stress, genome instability and aging
Q34337936DNA-PK, ATM and ATR collaboratively regulate p53-RPA interaction to facilitate homologous recombination DNA repair
Q64239237DRAM2 acts as an oncogene in non-small cell lung cancer and suppresses the expression of p53
Q37480033Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis.
Q38341405Doubles Game: Src-Stat3 versus p53-PTEN in Cellular Migration and Invasion
Q26784630Dysregulated metabolism contributes to oncogenesis
Q34645436Dysregulation of RNA polymerase I transcription during disease.
Q41829273EAPP modulates the activity of p21 and Chk2.
Q94468732Effect of linker on the binding free energy of stapled p53/HDM2 complex
Q92236941Effects of BCc1 nanoparticle and its mixture with doxorubicin on survival of murine 4T1 tumor model
Q30566367Effects of prostaglandin E2 on p53 mRNA transcription and p53 mutagenesis during T-cell-independent human B-cell clonal expansion
Q42381105Efficacy of Adoptive T-cell Therapy Is Improved by Treatment with the Antioxidant N-Acetyl Cysteine, Which Limits Activation-Induced T-cell Death
Q38590435Elevated ornithine decarboxylase levels activate ataxia telangiectasia mutated-DNA damage signaling in normal keratinocytes
Q64911207Epigenetic Control of Gene Expression in the Normal and Malignant Human Prostate: A Rapid Response Which Promotes Therapeutic Resistance.
Q37613538Evidence for ongoing DNA damage in multiple myeloma cells as revealed by constitutive phosphorylation of H2AX
Q36871709Experimental evolution reveals that high relatedness protects multicellular cooperation from cheaters
Q42256566Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence.
Q87182618Flaxseed (Linum usitatissimum L.) and its total non-digestible fraction influence the expression of genes involved in azoxymethane-induced colon cancer in rats
Q45835625From rheumatic diseases to cancer - role of autoantibodies as diagnostic biomarkers
Q39572618Fused Toes Homolog modulates radiation cytotoxicity in uterine cervical cancer cells.
Q33654494Hepatic p63 regulates steatosis via IKKβ/ER stress
Q33329233High LET radiation enhances apoptosis in mutated p53 cancer cells through Caspase-9 activation
Q36601446How do K-RAS-activated cells evade cellular defense mechanisms?
Q35051410Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population
Q34134333Human papillomavirus seropositivity synergizes with MDM2 variants to increase the risk of oral squamous cell carcinoma
Q47102885Hyperthermia exposure induces apoptosis and inhibits proliferation in HCT116 cells by upregulating miR-34a and causing transcriptional activation of p53.
Q28565709Identification and characterization of a novel Mdm2 splice variant acutely induced by the chemotherapeutic agents adriamycin and actinomycin D
Q37289310Immunohistochemistry Study of P53 and C-erbB-2 Expression in Trophoblastic Tissue and Their Predictive Values in Diagnosing Malignant Progression of Simple Molar Pregnancy
Q38086861Impact of EBV essential nuclear protein EBNA-3C on B-cell proliferation and apoptosis
Q28608667Impact of MDM2 309T>G polymorphism on sarcomagenesis
Q33997650Influence of p53 in the transition of myotrophin-induced cardiac hypertrophy to heart failure
Q37897197Interference with p53 functions in human viral infections, a target for novel antiviral strategies?
Q38162722Ionizing radiation-induced responses in human cells with differing TP53 status
Q28235883JDP2 (Jun Dimerization Protein 2)-deficient mouse embryonic fibroblasts are resistant to replicative senescence
Q37298409Jobelyn® Supplement Lowered Neuronal Degeneration: Significance of Altered p53 and ɤ-Enolase Protein Expressions in Prefrontal Cortex of Rat Exposed to Ethanol
Q33440643Limited role of murine ATM in oncogene-induced senescence and p53-dependent tumor suppression.
Q30988586Loss of p19(Arf) facilitates the angiogenic switch and tumor initiation in a multi-stage cancer model via p53-dependent and independent mechanisms
Q41947077Lysophosphatidic Acid Inhibits Apoptosis Induced by Cisplatin in Cervical Cancer Cells
Q98289749MAGEA3 promotes proliferation and suppresses apoptosis in cervical cancer cells by inhibiting the KAP1/p53 signaling pathway
Q42130135MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation
Q90571091MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance
Q59326864MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance
Q35563647Mcph1/Brit1 deficiency promotes genomic instability and tumor formation in a mouse model
Q89379344Measuring cell cycle-dependent DNA damage responses and p53 regulation on a cell-by-cell basis from image analysis
Q38648115Meta-analysis of clinical significance of p53 protein expression in patients with osteosarcoma
Q47850205Microscopy-based high-throughput assays enable multi-parametric analysis to assess adverse effects of nanomaterials in various cell lines
Q88178701Mitochondrial dysfunction suppresses p53 expression via calcium-mediated nuclear factor-kB signaling in HCT116 human colorectal carcinoma cells
Q33616298Mitochondrial matrix P53 sensitizes cells to oxidative stress
Q39468871Molecular characterization of TP53 gene in human populations exposed to low-dose ionizing radiation
Q37817718Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer
Q36068317Molecular dynamics-based identification of novel natural mortalin-p53 abrogators as anticancer agents
Q39992406Mycoplasma infection suppresses p53, activates NF-kappaB and cooperates with oncogenic Ras in rodent fibroblast transformation
Q36880375New insights into human papillomavirus-associated head and neck squamous cell carcinoma
Q83474479New insights into oncogenic stress
Q36151656Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice
Q92298314P53 expression in various types of hydropic placentas (through ploidy analysis as a complementary tool in diagnosis of samples)
Q33913135P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation
Q88640110Pathways of Metabolite-Related Damage to a Synthetic p53 Gene Exon 7 Oligonucleotide Using Magnetic Enzyme Bioreactor Beads and LC-MS/MS Sequencing
Q47228271Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis.
Q37052183Photoprotection in human skin--a multifaceted SOS response
Q33899450Posttranslational modification of p53: cooperative integrators of function
Q28476462Predicting transcriptional activity of multiple site p53 mutants based on hybrid properties
Q39570440Prognostic value of the TP53 Arg72Pro single-nucleotide polymorphism and susceptibility to medulloblastoma in a cohort of Brazilian patients
Q28708981Prototypes of newly conceived inorganic and biological sensors for health and environmental applications
Q43089122RECQ1 expression is upregulated in response to DNA damage and in a p53-dependent manner
Q42109676Radiation Sensitivity and Tumor Susceptibility in ATM Phospho-Mutant ATF2 Mice
Q34116777Radiation-induced cell death mechanisms
Q42801717Reconstitution of the cellular response to DNA damage in vitro using damage-activated extracts from mammalian cells
Q36985005Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation
Q27006998Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53
Q37447357Response of heterogeneous ribonuclear proteins (hnRNP) to ionising radiation and their involvement in DNA damage repair
Q58795265Resveratrol enhances cisplatin-induced apoptosis in human hepatoma cells via glutamine metabolism inhibition
Q33888327Retracted: Potential malignant transformation in the gastric mucosa of immunodeficient mice with persistent Mycoplasma penetrans infection
Q36311141Role of Gadd45a in Wip1-dependent regulation of intestinal tumorigenesis
Q92999956Role of RUNX Family Members in G1 Restriction-Point Regulation
Q64946390Role of p53 in the Regulation of the Inflammatory Tumor Microenvironment and Tumor Suppression.
Q34688242Runt-related transcription factor RUNX3 is a target of MDM2-mediated ubiquitination
Q24339585Runx3 inactivation is a crucial early event in the development of lung adenocarcinoma
Q43135527SOCS3 regulates p21 expression and cell cycle arrest in response to DNA damage.
Q54423137Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in Finnish breast cancer families.
Q27028052Senescence in adipose-derived stem cells and its implications in nerve regeneration
Q37788536Serine/threonine phosphatases in the DNA damage response and cancer
Q39269601Significance of Wild-Type p53 Signaling in Suppressing Apoptosis in Response to Chemical Genotoxic Agents: Impact on Chemotherapy Outcome
Q100395262Single molecule studies reveal that p53 tetramers dynamically bind response elements containing one or two half sites
Q28585092SnoN functions as a tumour suppressor by inducing premature senescence
Q35892810Sodium arsenite ± hyperthermia sensitizes p53-expressing human ovarian cancer cells to cisplatin by modulating platinum-DNA damage responses
Q51017453Studies of ATM Kinase Activity Using Engineered ATM Sensitive to ATP Analogues (ATM-AS).
Q34055695Suv4-20h abrogation enhances telomere elongation during reprogramming and confers a higher tumorigenic potential to iPS cells
Q39436606Synthesis of cytochrome C oxidase 2: a p53-dependent metabolic regulator that promotes respiratory function and protects glioma and colon cancer cells from hypoxia-induced cell death
Q91738289TC2N, a novel oncogene, accelerates tumor progression by suppressing p53 signaling pathway in lung cancer
Q35861964TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells
Q37177918TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy
Q36995054Targeting prostate cancer based on signal transduction and cell cycle pathways.
Q51800912The Role of Kinase Modulators in Cellular Senescence for Use in Cancer Treatment.
Q89666691The miR-34 family and its clinical significance in ovarian cancer
Q35831981The mitochondrial death pathway: a promising therapeutic target in diseases
Q28079723The paradox role of caspase cascade in ionizing radiation therapy
Q85790771The prognostic significance of p53 expression in gastric cancer: a meta-analysis
Q47106643The prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinoma.
Q28072553The role of p53 in cancer drug resistance and targeted chemotherapy
Q38042630Therapeutic strategies for head and neck cancer based on p53 status
Q58041514Tp53 gene p72R polymorphism in chronic lymphocytic leukemia: incidence and clinical significance amongst cases with unmutated immunoglobulin receptors
Q36061127Urothelial tumor initiation requires deregulation of multiple signaling pathways: implications in target-based therapies
Q37820433What is the best frontline therapy for patients with CLL and 17p deletion?
Q81886345[Von-Hippel-Lindau (VHL) protein function by initiation and progression of renal cancer]
Q36044626p53 and mitochondrial DNA: their role in mitochondrial homeostasis and toxicity of antiretrovirals
Q37689054p53 increase mitochondrial copy number via up-regulation of mitochondrial transcription factor A in colorectal cancer
Q37344805p53 mutations associated with aging-related rise in cancer incidence rates
Q37247096p53 promotes inflammation-associated hepatocarcinogenesis by inducing HMGB1 release
Q37821711p53 regulation of podosome formation and cellular invasion in vascular smooth muscle cells
Q39707367p53-Dependent p21-mediated growth arrest pre-empts and protects HCT116 cells from PUMA-mediated apoptosis induced by EGCG.
Q39984297p53-mediated control of gene expression via mRNA translation during Endoplasmic Reticulum stress

Search more.